DLC1 and breast carcinoma: Although DLC1 (13.2 Mb) has a tumour suppressive effect in a variety of tumour types, including breast cancer (e.g. [40]), it was not a likely target of these 8p22 rearrangements as it lay just outside the rearrangements in all except one case.